MétaCan
Menu
← Back to cohort
Record W7084188825

Post-Marketing Safety Concerns with Efgartigimod alfa: A Pharmacovigilance Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database

2025· article· en· W7084188825 on OpenAlexaboutno aff

Bibliographic record

VenueDOAJ (DOAJ: Directory of Open Access Journals) · 2025
Typearticle
Languageen
FieldEnergy
TopicElectrocatalysts for Energy Conversion
Canadian institutionsnot available
Fundersnot available
KeywordsPharmacovigilanceAdverse Event Reporting SystemConfidence intervalAdverse drug eventPoisson regressionOdds ratioQuarter (Canadian coin)Adverse effect
DOInot available

Abstract

fetched live from OpenAlex

Jinlong Huang,1,2 Hanyun Ye,1 Jingyang Lin,3 Dan Luo,1,2 Ping Huang,1 Xiaochun Zheng1,2 1Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China; 2School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, People’s Republic of China; 3Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Ping Huang, Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, 158 Shangtang Road, Gongsu District, Hangzhou, Zhejiang, 310014, People’s Republic of China, Email huangpwly@sina.com Xiaochun Zheng, Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, 158 Shangtang Road, Gongsu District, Hangzhou, Zhejiang, 310014, People’s Republic of China, Email 13868109173@126.comAim: Efgartigimod alfa (EA) is a novel US Food and Drug Administration (FDA) approved neonatal Fc receptor-targeting drug; however, its real-world adverse event (AE) profile remains underexplored.Methods: AE reports primarily related to EA were retrieved from the US FDA Adverse Event Reporting System database for the fourth quarter of 2021 to the third quarter of 2024. Disproportionality analysis using Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network, and Multi-item Gamma Poisson Shrinker algorithms was employed to detect signals of AEs.Results: Our study processed 3,182 AE reports related to EA, revealing 57 signals that met the criteria of the ROR, PRR, Bayesian Confidence Propagation Neural Network, and Multi-item Gamma Poisson Shrinker algorithms across 14 system organ classes. Notably, the most significant signal in the System Organ Class was “Surgical and medical procedures”, whereas the most significant signal in Preferred Term was “Bulbar Palsy”. Some unexpected over-the-counter AEs, including falls, choking, sepsis, nephrolithiasis, and atrial fibrillation, were also observed. The median onset time of EA-related AEs was 101.5 d (interquartile range 27– 260). The AE risk model associated with EA should be referred to as “early failure”, with the likelihood of AEs decreasing over time.Conclusion: This study highlights the potential AEs and risks associated with the clinical use of EA; the analysis provides significant evidence regarding the clinical safety of EA.Keywords: efgartigimod alfa, myasthenia gravis, signal mining, adverse events

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.018
metaresearch head score (Gemma)0.037
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.018
Threshold uncertainty score0.097

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0180.037
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.004
Bibliometrics0.0040.005
Science and technology studies0.0010.000
Scholarly communication0.0030.002
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.076
GPT teacher head0.454
Teacher spread0.378 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueDOAJ (DOAJ: Directory of Open Access Journals)→Same topicElectrocatalysts for Energy Conversion→French-language works237,207→